These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 19164344)

  • 1. Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD.
    Lomas DA; Silverman EK; Edwards LD; Locantore NW; Miller BE; Horstman DH; Tal-Singer R;
    Eur Respir J; 2009 Jul; 34(1):95-102. PubMed ID: 19164344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive characterisation of pulmonary and serum surfactant protein D in COPD.
    Winkler C; Atochina-Vasserman EN; Holz O; Beers MF; Erpenbeck VJ; Krug N; Roepcke S; Lauer G; Elmlinger M; Hohlfeld JM
    Respir Res; 2011 Mar; 12(1):29. PubMed ID: 21396106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of full-length, cleaved and nitrosylated serum surfactant protein D as biomarkers for COPD.
    Duvoix A; Miranda E; Perez J; Sorensen GL; Holmskov U; Trapnell BC; Madsen J; Clark HW; Edwards LD; Miller BE; Tal-Singer RM; Lomas DA
    COPD; 2011 Apr; 8(2):79-95. PubMed ID: 21495836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum surfactant protein-A, but not surfactant protein-D or KL-6, can predict preclinical lung damage induced by smoking.
    Kobayashi H; Kanoh S; Motoyoshi K
    Biomarkers; 2008 Jun; 13(4):385-92. PubMed ID: 18595202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum surfactant protein D during acute exacerbations of chronic obstructive pulmonary disease.
    Shakoori TA; Sin DD; Ghafoor F; Bashir S; Bokhari SN
    Dis Markers; 2009; 27(6):287-94. PubMed ID: 20075511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of surfactant protein A, surfactant protein D, Clara cell protein 16, S100 protein, trefoil factor 3, and prostatic secretory protein 94 in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease.
    Doubková M; Karpíšek M; Mazoch J; Skřičková J; Doubek M
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):224-234. PubMed ID: 27758987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fucosylated surfactant protein-D is a biomarker candidate for the development of chronic obstructive pulmonary disease.
    Ito E; Oka R; Ishii T; Korekane H; Kurimoto A; Kizuka Y; Kitazume S; Ariki S; Takahashi M; Kuroki Y; Kida K; Taniguchi N
    J Proteomics; 2015 Sep; 127(Pt B):386-94. PubMed ID: 26206179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum Surfactant Protein Levels in Patients Admitted to the Hospital with Acute COPD Exacerbation.
    Papaioannou AI; Konstantelou E; Papaporfyriou A; Bartziokas K; Spathis A; Bakakos P; Loukides S; Koulouris N; Papiris S; Kostikas K
    Lung; 2018 Apr; 196(2):201-205. PubMed ID: 29445934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Surfactant Protein D is a Potential Biomarker for Chronic Obstructive Pulmonary Disease: a Systematic Review and Meta-analysis.
    Wang H; Li F; Huang H; Wu F; Chen L; Zhang D; Zhang T; Wan Y
    Clin Lab; 2019 Dec; 65(12):. PubMed ID: 31850711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The presence and progression of emphysema in COPD as determined by CT scanning and biomarker expression: a prospective analysis from the ECLIPSE study.
    Coxson HO; Dirksen A; Edwards LD; Yates JC; Agusti A; Bakke P; Calverley PM; Celli B; Crim C; Duvoix A; Fauerbach PN; Lomas DA; Macnee W; Mayer RJ; Miller BE; Müller NL; Rennard SI; Silverman EK; Tal-Singer R; Wouters EF; Vestbo J;
    Lancet Respir Med; 2013 Apr; 1(2):129-36. PubMed ID: 24429093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variants of pulmonary SP-D predict disease outcome of COPD in a Chinese population.
    Ou CY; Chen CZ; Hsiue TR; Lin SH; Wang JY
    Respirology; 2015 Feb; 20(2):296-303. PubMed ID: 25376584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evaluation of serum surfactant protein D (SP-D) levels as a biomarker of lung injury in tuberculosis and different lung diseases.
    Güzel A; Karadağ A; Okuyucu A; Alaçam H; Küçük Y
    Clin Lab; 2014; 60(7):1091-8. PubMed ID: 25134376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of serum CC-16 as a biomarker for COPD in the ECLIPSE cohort.
    Lomas DA; Silverman EK; Edwards LD; Miller BE; Coxson HO; Tal-Singer R;
    Thorax; 2008 Dec; 63(12):1058-63. PubMed ID: 18757456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum surfactant protein D: biomarker of chronic obstructive pulmonary disease.
    Ju CR; Liu W; Chen RC
    Dis Markers; 2012; 32(5):281-7. PubMed ID: 22674408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surfactant protein D as a biomarker for chronic obstructive pulmonary disease.
    Bowler RP
    COPD; 2012 Dec; 9(6):651-3. PubMed ID: 23244171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surfactant protein D is a causal risk factor for COPD: results of Mendelian randomisation.
    Obeidat M; Li X; Burgess S; Zhou G; Fishbane N; Hansel NN; Bossé Y; Joubert P; Hao K; Nickle DC; van den Berge M; Timens W; Cho MH; Hobbs BD; de Jong K; Boezen M; Hung RJ; Rafaels N; Mathias R; Ruczinski I; Beaty TH; Barnes KC; Paré PD; Sin DD;
    Eur Respir J; 2017 Nov; 50(5):. PubMed ID: 29191953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphisms of surfactant protein D rs2243639, Interleukin (IL)-1β rs16944 and IL-1RN rs2234663 in chronic obstructive pulmonary disease, healthy smokers, and non-smokers.
    Issac MS; Ashur W; Mousa H
    Mol Diagn Ther; 2014 Jun; 18(3):343-54. PubMed ID: 24504887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COPD association and repeatability of blood biomarkers in the ECLIPSE cohort.
    Dickens JA; Miller BE; Edwards LD; Silverman EK; Lomas DA; Tal-Singer R;
    Respir Res; 2011 Nov; 12(1):146. PubMed ID: 22054035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms in surfactant protein-D are associated with chronic obstructive pulmonary disease.
    Foreman MG; Kong X; DeMeo DL; Pillai SG; Hersh CP; Bakke P; Gulsvik A; Lomas DA; Litonjua AA; Shapiro SD; Tal-Singer R; Silverman EK
    Am J Respir Cell Mol Biol; 2011 Mar; 44(3):316-22. PubMed ID: 20448057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of serum surfactant protein D as a biomarker of exacerbation of chronic obstructive pulmonary disease.
    Zien Alaabden A; Mohammad Y; Fahoum S
    Qatar Med J; 2015; 2015(2):18. PubMed ID: 26942111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.